Viewing Study NCT00157560


Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2026-03-14 @ 9:36 PM
Study NCT ID: NCT00157560
Status: COMPLETED
Last Update Posted: 2008-01-03
First Post: 2005-09-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Study of Modified Triple Doublet Therapy in Women With Newly Diagnosed Mullerian Carcinoma
Sponsor: Massachusetts General Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
None Fallopian Tube Cancer View
None Primary Peritoneal Cancer View
Keywords: